AntiemeticsDimplingHormoneReplacementTherapyOligometastasesDocetaxelTriple +/-BreastCancerAdvocacyLymphoscintigraphyBreastTomosynthesisMultifocalTumorsCyclophosphamideStagingRaloxifeneMultimodalityTherapyCytostaticCachexiaChemopreventionGeneticCounselingFlowCytometryWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AnastrozoleKi-67RateBI-RADSCystEGFRAyurvedamTORInhibitorsMRIBilateralProphylacticMastectomyKappaEpsilonDoxorubicinFamilyHistoryCAMLump1 in 8womenGailModelPathologicResponseBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltRADACChemotherapyAngiogenesisBrachytherapyMetastasisLumpectomyDown-StagingPrecisionMedicineAdenocarcinomaSelf-examinationLapatinib5-FluorouracilIntraductalPapillomaTumorGradeMorpheaRelapseNeoadjuvantTherapyLymphNodeStatusBiopsyChemotherapyHerceptinAromataseInhibitorsIn-situCarcinomaCheckpointInhibitorAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenEstrogen/EstradiolFISHTamoxifenCalcificationsCo-survivorAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPalbociclibGermlineMutationProgestinApoptosisAlopeciaPARPInhibitorsAbsoluteRiskBOCAMastodyniaWomen ages40+ shouldhave a clinicalbreast examat least yearlyPalpationCDK4/6InhibitorsAntibodyTherapyMegestrolAcetateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMethotrexateGeneticPredispositionGeneMutationGuaranteedRenewableInsurancePaclitaxelHER-2DefinitiveSurgeryCapecitabineAdjuvantTherapyDoseDenseTherapyPhyllodesTumorCMFChemotherapyHormoneReceptorStatusImmunotherapyPagetDiseaseBreastCancerER+/-FibroadenomaOvarianSuppressionSERMBevacizumabLCISCytotoxicFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.PI3KinaseInhibitorsECOGScoreMastectomyTyrosine-KinaseInhibitorPhysicalactivity mayreduce therisk of breastcancersBRCAGeneRadiotherapyAntiemeticsDimplingHormoneReplacementTherapyOligometastasesDocetaxelTriple +/-BreastCancerAdvocacyLymphoscintigraphyBreastTomosynthesisMultifocalTumorsCyclophosphamideStagingRaloxifeneMultimodalityTherapyCytostaticCachexiaChemopreventionGeneticCounselingFlowCytometryWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AnastrozoleKi-67RateBI-RADSCystEGFRAyurvedamTORInhibitorsMRIBilateralProphylacticMastectomyKappaEpsilonDoxorubicinFamilyHistoryCAMLump1 in 8womenGailModelPathologicResponseBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltRADACChemotherapyAngiogenesisBrachytherapyMetastasisLumpectomyDown-StagingPrecisionMedicineAdenocarcinomaSelf-examinationLapatinib5-FluorouracilIntraductalPapillomaTumorGradeMorpheaRelapseNeoadjuvantTherapyLymphNodeStatusBiopsyChemotherapyHerceptinAromataseInhibitorsIn-situCarcinomaCheckpointInhibitorAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenEstrogen/EstradiolFISHTamoxifenCalcificationsCo-survivorAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPalbociclibGermlineMutationProgestinApoptosisAlopeciaPARPInhibitorsAbsoluteRiskBOCAMastodyniaWomen ages40+ shouldhave a clinicalbreast examat least yearlyPalpationCDK4/6InhibitorsAntibodyTherapyMegestrolAcetateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMethotrexateGeneticPredispositionGeneMutationGuaranteedRenewableInsurancePaclitaxelHER-2DefinitiveSurgeryCapecitabineAdjuvantTherapyDoseDenseTherapyPhyllodesTumorCMFChemotherapyHormoneReceptorStatusImmunotherapyPagetDiseaseBreastCancerER+/-FibroadenomaOvarianSuppressionSERMBevacizumabLCISCytotoxicFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.PI3KinaseInhibitorsECOGScoreMastectomyTyrosine-KinaseInhibitorPhysicalactivity mayreduce therisk of breastcancersBRCAGeneRadiotherapy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Antiemetics
  2. Dimpling
  3. Hormone Replacement Therapy
  4. Oligometastases
  5. Docetaxel
  6. Triple +/- Breast Cancer
  7. Advocacy
  8. Lymphoscintigraphy
  9. Breast Tomosynthesis
  10. Multifocal Tumors
  11. Cyclophosphamide
  12. Staging
  13. Raloxifene
  14. Multimodality Therapy
  15. Cytostatic
  16. Cachexia
  17. Chemoprevention
  18. Genetic Counseling
  19. Flow Cytometry
  20. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  21. Anastrozole
  22. Ki-67 Rate
  23. BI-RADS
  24. Cyst
  25. EGFR
  26. Ayurveda
  27. mTOR Inhibitors
  28. MRI
  29. Bilateral Prophylactic Mastectomy
  30. Kappa Epsilon
  31. Doxorubicin
  32. Family History
  33. CAM
  34. Lump
  35. 1 in 8 women
  36. Gail Model
  37. Pathologic Response
  38. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  39. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  40. RAD
  41. AC Chemotherapy
  42. Angiogenesis
  43. Brachytherapy
  44. Metastasis
  45. Lumpectomy
  46. Down-Staging
  47. Precision Medicine
  48. Adenocarcinoma
  49. Self-examination
  50. Lapatinib
  51. 5-Fluorouracil
  52. Intraductal Papilloma
  53. Tumor Grade
  54. Morphea
  55. Relapse
  56. Neoadjuvant Therapy
  57. Lymph Node Status
  58. Biopsy
  59. Chemotherapy
  60. Herceptin
  61. Aromatase Inhibitors
  62. In-situ Carcinoma
  63. Checkpoint Inhibitor
  64. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  65. Estrogen/Estradiol
  66. FISH
  67. Tamoxifen
  68. Calcifications
  69. Co-survivor
  70. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  71. Palbociclib
  72. Germline Mutation
  73. Progestin
  74. Apoptosis
  75. Alopecia
  76. PARP Inhibitors
  77. Absolute Risk
  78. BOCA
  79. Mastodynia
  80. Women ages 40+ should have a clinical breast exam at least yearly
  81. Palpation
  82. CDK4/6 Inhibitors
  83. Antibody Therapy
  84. Megestrol Acetate
  85. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  86. Methotrexate
  87. Genetic Predisposition
  88. Gene Mutation
  89. Guaranteed Renewable Insurance
  90. Paclitaxel
  91. HER-2
  92. Definitive Surgery
  93. Capecitabine
  94. Adjuvant Therapy
  95. Dose Dense Therapy
  96. Phyllodes Tumor
  97. CMF Chemotherapy
  98. Hormone Receptor Status
  99. Immunotherapy
  100. Paget Disease
  101. Breast Cancer
  102. ER +/-
  103. Fibroadenoma
  104. Ovarian Suppression
  105. SERM
  106. Bevacizumab
  107. LCIS
  108. Cytotoxic
  109. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  110. PI3 Kinase Inhibitors
  111. ECOG Score
  112. Mastectomy
  113. Tyrosine-Kinase Inhibitor
  114. Physical activity may reduce the risk of breast cancers
  115. BRCA Gene
  116. Radiotherapy